Search this Site

Brand Name(s): Lotensin
CAS nš: 86541-75-5
(ben ay' ze pril)

About Benazepril

This new site is dedicated exclusively to benazepril, also known as
benazepril hydrochlorothiazide.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about benazepril, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total benazepril experience! 

Why is this medication prescribed?

Benazepril is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure.

Benazepril is an ACE (angiotensin converting enzyme) inhibitor. ACE is an enzyme in the body which is important for the formation of angiotensin II. Angiotensin II causes constriction of arteries in the body, thereby elevating blood pressure. ACE inhibitors such as benazepril lower blood pressure by inhibiting the formation of angiotensin II, thus relaxing the arteries. Relaxing the arteries not only lowers blood pressure, but also improves the pumping efficiency of a failing heart and improves cardiac output in patients with heart failure. 

See more Product Info

Latest News

Cadila to market benazepril tablets in U.S.

Drug maker Cadila Healthcare Ltd said on Monday its Zydus Cadila unit received the U.S.

[more]

Higher-Dose Amlodipine Besylate/Benazepril HCl Capsules (Lotrel) for Managing Hypertension

On April 11, the FDA approved 5-mg/40-mg and 10-mg/40-mg amlodipine besylate/benazepril HCl...

[more]

FDA Approves New Lotrel 5/40 mg and 10/40 mg Dosage Strengths

Novartis Pharmaceuticals Corporation announced it has received marketing approval from the U.S....

[more]

Aldactone Added to ACE or ARB Reduces Albuminuria in Type 2 Diabetes

For type 2 diabetes with albuminuria persisting despite ACE inhibitors or angiotensin receptor...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.